{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:15:57Z","timestamp":1791951357681,"version":"4.3.4"},"reference-count":211,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["R01 AI140405"],"award-info":[{"award-number":["R01 AI140405"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007271","name":"Health Science Center, University of Tennessee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.apsb.2025.04.029","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T12:04:03Z","timestamp":1746446643000},"page":"2930-2944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Obesity\u2013cancer axis crosstalk: Molecular insights and therapeutic approaches"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3335-0368","authenticated-orcid":false,"given":"Ahmed","family":"Rakib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Abdullah Al","family":"Mamun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8131-1668","authenticated-orcid":false,"given":"Mousumi","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priti","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7048-4325","authenticated-orcid":false,"given":"Udai P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2025.04.029_bib1","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2300096121","article-title":"DIDO is necessary for the adipogenesis that promotes diet-induced obesity","volume":"121","author":"Garc\u00eda-L\u00f3pez","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2025.04.029_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fendo.2016.00030","article-title":"Adipose tissue remodeling: its role in energy metabolism and metabolic disorders","volume":"7","author":"Choe","year":"2016","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.apsb.2025.04.029_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders","volume":"542","author":"Hotamisligil","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.029_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1210\/endrev\/bnz014","article-title":"Diabetes, obesity, and cancer\u2014pathophysiology and clinical implications","volume":"41","author":"Lega","year":"2020","journal-title":"Endocr Rev"},{"key":"10.1016\/j.apsb.2025.04.029_bib5","doi-asserted-by":"crossref","first-page":"8753","DOI":"10.1073\/pnas.1308182110","article-title":"Link between obesity and cancer","volume":"110","author":"Williams","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2025.04.029_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.metabol.2018.11.001","article-title":"Obesity and cancer risk: emerging biological mechanisms and perspectives","volume":"92","author":"Avgerinos","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.apsb.2025.04.029_bib7","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaci.2005.02.023","article-title":"Adipose tissue, adipokines, and inflammation","volume":"115","author":"Fantuzzi","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.apsb.2025.04.029_bib8","first-page":"1148","volume":"358","author":"Esteller","year":"2008","journal-title":"Epigenetics in cancer. N Engl J Med."},{"key":"10.1016\/j.apsb.2025.04.029_bib9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.arcmed.2008.09.005","article-title":"White adipose tissue as endocrine organ and its role in obesity","volume":"39","author":"V\u00e1zquez-Vela","year":"2008","journal-title":"Arch Med Res"},{"key":"10.1016\/j.apsb.2025.04.029_bib10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.apsb.2025.04.029_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12979-022-00320-w","article-title":"MicroRNAs: a crossroad that connects obesity to immunity and aging","volume":"19","author":"Rakib","year":"2022","journal-title":"Immun Ageing"},{"key":"10.1016\/j.apsb.2025.04.029_bib12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.029_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3945\/an.115.010207","article-title":"Impact of obesity and metabolic syndrome on immunity","volume":"7","author":"Andersen","year":"2016","journal-title":"Adv Nutr"},{"key":"10.1016\/j.apsb.2025.04.029_bib14","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.3390\/cancers12123798","article-title":"Obesity and cancer metastasis: molecular and translational perspectives","volume":"12","author":"Annett","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.apsb.2025.04.029_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1194931","article-title":"Gut colonization with an obesity-associated enteropathogenic microbe modulates the premetastatic niches to promote breast cancer lung and liver metastasis","volume":"14","author":"Parida","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2025.04.029_bib16","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41366-022-01178-0","article-title":"Obesity and \u201cobesity-related\u201d cancers: are there body mass index cut-points?.","volume":"46","author":"Murtha","year":"2022","journal-title":"Int J Obes"},{"key":"10.1016\/j.apsb.2025.04.029_bib17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s13679-021-00426-0","article-title":"Gender differences in obesity-related cancers","volume":"10","author":"Argyrakopoulou","year":"2021","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.apsb.2025.04.029_bib18","first-page":"88","article-title":"Global patterns in excess body weight and the associated cancer burden","volume":"69","author":"Sung","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.apsb.2025.04.029_bib19","first-page":"1183","article-title":"World Cancer Research Fund International: continuous Update Project\u2014systematic literature review and meta-analysis of observational cohort studies on physical activity, sedentary behavior, adiposity, and weight change and breast cancer risk","volume":"30","author":"Chan","year":"2019","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.apsb.2025.04.029_bib20","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/gutjnl-2013-304701","article-title":"Obesity and colorectal cancer","volume":"62","author":"Bardou","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2025.04.029_bib21","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1158\/1940-6207.CAPR-15-0061","article-title":"Adulthood weight change and risk of colorectal cancer in the nurses' health study and health professionals follow-up study","volume":"8","author":"Song","year":"2015","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.apsb.2025.04.029_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1756283X13501786","article-title":"The role of obesity in gastrointestinal cancer: evidence and opinion","volume":"7","author":"Donohoe","year":"2014","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.apsb.2025.04.029_bib23","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.3390\/ijms21176039","article-title":"There and back again: leptin actions in white adipose tissue","volume":"21","author":"Mart\u00ednez-S\u00e1nchez","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.04.029_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/obr.12958","article-title":"White adipose tissue mitochondrial metabolism in health and in obesity","volume":"21","author":"Heinonen","year":"2020","journal-title":"Obes Rev"},{"key":"10.1016\/j.apsb.2025.04.029_bib25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41574-023-00893-6","article-title":"The evolving functions of the vasculature in regulating adipose tissue biology in health and obesity","volume":"19","author":"AlZaim","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.apsb.2025.04.029_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrneph.2017.157","article-title":"Immunologic and endocrine functions of adipose tissue: implications for kidney disease","volume":"14","author":"Zhu","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.apsb.2025.04.029_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nrendo.2016.136","article-title":"Brown adipose tissue as a secretory organ","volume":"13","author":"Villarroya","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.apsb.2025.04.029_bib28","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3390\/ijms24021422","article-title":"Recent advances in the knowledge of the mechanisms of leptin physiology and actions in neurological and metabolic pathologies","volume":"24","author":"Casado","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.04.029_bib29","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.3390\/nu15153445","article-title":"Adipose tissue hyperplasia and hypertrophy in common and syndromic obesity\u2014the case of BBS obesity","volume":"15","author":"Horwitz","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.apsb.2025.04.029_bib30","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.3390\/ijms25042338","article-title":"Role of leptin in obesity, cardiovascular disease, and type 2 diabetes","volume":"25","author":"Vilari\u00f1o-Garc\u00eda","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.04.029_bib31","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/sj.ijo.0800779","article-title":"Leptin resistance in obese humans: does it exist and what does it mean?.","volume":"22","author":"Arch","year":"1998","journal-title":"Int J Obes"},{"key":"10.1016\/j.apsb.2025.04.029_bib32","doi-asserted-by":"crossref","first-page":"R1557","DOI":"10.1152\/ajpregu.00860.2005","article-title":"Direct and indirect effects of leptin on preadipocyte proliferation and differentiation","volume":"290","author":"Wagoner","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.apsb.2025.04.029_bib33","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.3390\/cancers15174250","article-title":"Role of leptin and adiponectin in carcinogenesis","volume":"15","author":"Bocian-Jastrz\u0119bska","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.apsb.2025.04.029_bib34","first-page":"939","article-title":"Leptin and mToR","volume":"13","author":"Dempsey","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2025.04.029_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1238528","article-title":"Leptin signaling and its central role in energy homeostasis","volume":"17","author":"Liu","year":"2023","journal-title":"Front Neurosci"},{"key":"10.1016\/j.apsb.2025.04.029_bib36","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.3390\/ijms22062870","article-title":"Leptin and cancer: updated functional roles in carcinogenesis, therapeutic niches, and developments","volume":"22","author":"Lin","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.04.029_bib37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/sj.bjc.6606013","article-title":"Leptin pro-angiogenic signature in breast cancer is linked to IL-1 signalling","volume":"104","author":"Zhou","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.apsb.2025.04.029_bib38","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1210\/endo.138.11.5651","article-title":"Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob\/ob mice","volume":"138","author":"Thornton","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.apsb.2025.04.029_bib39","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.4049\/jimmunol.1502643","article-title":"Genetic and epigenetic regulation of PD-1 expression","volume":"196","author":"Bally","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2025.04.029_bib40","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/0022034517712435","article-title":"STAT3 induces immunosuppression by upregulating PD-1\/PD-L1 in HNSCC","volume":"96","author":"Bu","year":"2017","journal-title":"J Dent Res"},{"key":"10.1016\/j.apsb.2025.04.029_bib41","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1158\/0008-5472.CAN-04-2425","article-title":"Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice","volume":"65","author":"Ling","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2025.04.029_bib42","doi-asserted-by":"crossref","first-page":"26320","DOI":"10.1074\/jbc.M601991200","article-title":"Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2)","volume":"281","author":"Gonzalez","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2025.04.029_bib43","article-title":"Quantification of STAT3 and VEGF expression for molecular diagnosis of lymph node metastasis in breast cancer","volume":"96","author":"Chen","year":"2017","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.apsb.2025.04.029_bib44","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3390\/ijms20040839","article-title":"Adiponectin as link factor between adipose tissue and cancer","volume":"20","author":"Di Zazzo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.04.029_bib45","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","article-title":"Cloning of adiponectin receptors that mediate antidiabetic metabolic effects","volume":"423","author":"Yamauchi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.029_bib46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jmcb\/mjw014","article-title":"Adiponectin signaling and function in insulin target tissues","volume":"8","author":"Ruan","year":"2016","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.apsb.2025.04.029_bib47","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1210\/en.2015-1066","article-title":"Adiponectin-mediated antilipotoxic effects in regenerating pancreatic islets","volume":"156","author":"Ye","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.apsb.2025.04.029_bib48","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nm1557","article-title":"Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions","volume":"13","author":"Yamauchi","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2025.04.029_bib49","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.celrep.2014.04.006","article-title":"APPL1 potentiates insulin sensitivity by facilitating the binding of IRS1\/2 to the insulin receptor","volume":"7","author":"Ryu","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2025.04.029_bib50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11010-018-3319-7","article-title":"Adiponectin and colon cancer: evidence for inhibitory effects on viability and migration of human colorectal cell lines","volume":"448","author":"Nigro","year":"2018","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.apsb.2025.04.029_bib51","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1080\/15548627.2017.1332565","article-title":"ADIPOQ\/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11\/LKB1-mediated activation of the AMPK\u2013ULK1 axis","volume":"13","author":"Chung","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2025.04.029_bib52","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1007\/s10620-014-3175-6","article-title":"Adiponectin inhibits murine pancreatic cancer growth","volume":"59","author":"Kato","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.apsb.2025.04.029_bib53","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.18632\/oncotarget.1963","article-title":"Adiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK\/Sirt1\/PGC-1\u03b1 signaling","volume":"5","author":"Huang","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2025.04.029_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-021-02223-y","article-title":"Adiponectin triggers breast cancer cell death via fatty acid metabolic reprogramming","volume":"41","author":"Pham","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.apsb.2025.04.029_bib55","doi-asserted-by":"crossref","first-page":"28670","DOI":"10.1074\/jbc.M402558200","article-title":"Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling","volume":"279","author":"Shibata","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2025.04.029_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119524","article-title":"The bifurcated role of adiponectin in colorectal cancer","volume":"278","author":"Chakraborty","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.apsb.2025.04.029_bib57","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41419-024-07084-9","article-title":"Uncovering the connection between obesity and thyroid cancer: the therapeutic potential of adiponectin receptor agonist in the AdipoR2\u2013ULK axis","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2025.04.029_bib58","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.5479","article-title":"Adiponectin promotes VEGF-A-dependent angiogenesis in human chondrosarcoma through PI3K, Akt, mTOR, and HIF-\u03b1 pathway","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2025.04.029_bib59","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3892\/mmr.2024.13219","article-title":"Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation-mediating treatment options","volume":"29","author":"Varra","year":"2024","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.apsb.2025.04.029_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1213415","article-title":"miR-10a-3p modulates adiposity and suppresses adipose inflammation through TGF-\u03b21\/Smad3 signaling pathway","volume":"14","author":"Kiran","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2025.04.029_bib61","article-title":"Obesity: a chronic low-grade inflammation and its markers","volume":"14","author":"Khanna","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.apsb.2025.04.029_bib62","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/ITT.S73223","article-title":"The role of adipokines in chronic inflammation","volume":"5","author":"Mancuso","year":"2016","journal-title":"ImmunoTargets Ther"},{"key":"10.1016\/j.apsb.2025.04.029_bib63","doi-asserted-by":"crossref","first-page":"E656","DOI":"10.1152\/ajpendo.00127.2007","article-title":"Adipokines oversecreted by omental adipose tissue in human obesity","volume":"293","author":"Maury","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.apsb.2025.04.029_bib64","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.1038\/s41467-022-34110-1","article-title":"REDD1 promotes obesity-induced metabolic dysfunction via atypical NF-\u03baB activation","volume":"13","author":"Lee","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.04.029_bib65","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/802078","article-title":"The role of adipose tissue and adipokines in obesity-related inflammatory diseases","volume":"2010","author":"Balistreri","year":"2010","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.apsb.2025.04.029_bib66","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nm.2002","article-title":"Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters","volume":"15","author":"Feuerer","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2025.04.029_bib67","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nm.1964","article-title":"CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity","volume":"15","author":"Nishimura","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2025.04.029_bib68","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nm.2885","article-title":"Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase","volume":"18","author":"Talukdar","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2025.04.029_bib69","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41591-018-0221-5","article-title":"Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade","volume":"25","author":"Wang","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2025.04.029_bib70","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev-bioeng-110320-110749","article-title":"Cell trafficking at the intersection of the tumor\u2013immune compartments","volume":"24","author":"Du","year":"2022","journal-title":"Annu Rev Biomed Eng"},{"key":"10.1016\/j.apsb.2025.04.029_bib71","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/bjc.2013.32","article-title":"Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer","volume":"108","author":"Ino","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.apsb.2025.04.029_bib72","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?.","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2025.04.029_bib73","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.029_bib74","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2025.04.029_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer\u2013immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2025.04.029_bib76","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ccr.2009.01.001","article-title":"IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer","volume":"15","author":"Grivennikov","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2025.04.029_bib77","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2025.04.029_bib78","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1073\/pnas.1920004117","article-title":"Regulation of adipose tissue inflammation by interleukin 6","volume":"117","author":"Han","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2025.04.029_bib79","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nri1995","article-title":"Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment","volume":"7","author":"Yu","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2025.04.029_bib80","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2009.01.002","article-title":"GP130-mediated STAT3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis","volume":"15","author":"Bollrath","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2025.04.029_bib81","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.canlet.2013.09.017","article-title":"Bone marrow-derived myofibroblasts promote colon tumorigenesis through the IL-6\/JAK2\/STAT3 pathway","volume":"343","author":"Zhu","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2025.04.029_bib82","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int Immunol"},{"key":"10.1016\/j.apsb.2025.04.029_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-015-0276-9","article-title":"PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value","volume":"35","author":"Xu","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.apsb.2025.04.029_bib84","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/sj.onc.1206226","article-title":"Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway","volume":"22","author":"Wei","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2025.04.029_bib85","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1038\/sj.onc.1208719","article-title":"Targeting STAT3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways","volume":"24","author":"Xu","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2025.04.029_bib86","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","article-title":"NF-\u03baB, an active player in human cancers","volume":"2","author":"Xia","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.apsb.2025.04.029_bib87","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2017089118","article-title":"TAp73 represses NF-\u03baB\u2013mediated recruitment of tumor-associated macrophages in breast cancer","volume":"118","author":"Wolfsberger","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2025.04.029_bib88","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1038\/s41467-022-32348-3","article-title":"EGFR-mediated activation of adipose tissue macrophages promotes obesity and insulin resistance","volume":"13","author":"Cao","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.04.029_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijo.2022.5347","article-title":"Role of macrophages in tumor progression and therapy","volume":"60","author":"Xu","year":"2022","journal-title":"Int J Oncol"},{"key":"10.1016\/j.apsb.2025.04.029_bib90","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc1388","article-title":"Cancer and the chemokine network","volume":"4","author":"Balkwill","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2025.04.029_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-014-0352-6","article-title":"Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10\/STAT3\/BCL-2 signaling pathway","volume":"32","author":"Yang","year":"2015","journal-title":"Med Oncol"},{"key":"10.1016\/j.apsb.2025.04.029_bib92","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ni.2865","article-title":"Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin","volume":"15","author":"Mauer","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2025.04.029_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-017-0430-2","article-title":"Tumor-associated macrophages: from basic research to clinical application","volume":"10","author":"Yang","year":"2017","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2025.04.029_bib94","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2025.04.029_bib95","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cmet.2010.11.011","article-title":"The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity","volume":"12","author":"Stienstra","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2025.04.029_bib96","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2025.04.029_bib97","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.immuni.2010.03.003","article-title":"The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis","volume":"32","author":"Zaki","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2025.04.029_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1195572","article-title":"The roles of inflammasomes in cancer","volume":"14","author":"Deng","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2025.04.029_bib99","first-page":"481","article-title":"Inflammasomes in colitis and colorectal cancer: mechanism of action and therapies","volume":"92","author":"Pandey","year":"2019","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.apsb.2025.04.029_bib100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2025.04.029_bib101","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ccr.2008.10.011","article-title":"Overexpression of interleukin-1\u03b2 induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice","volume":"14","author":"Tu","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2025.04.029_bib102","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.11276","article-title":"IL-1\u03b1 and IL-1\u03b2-producing macrophages populate lung tumor lesions in mice","volume":"7","author":"Terlizzi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2025.04.029_bib103","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.taap.2013.03.027","article-title":"Thymoquinone suppresses metastasis of melanoma cells by inhibition of NLRP3 inflammasome","volume":"270","author":"Ahmad","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.apsb.2025.04.029_bib104","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41467-020-20500-w","article-title":"High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance","volume":"12","author":"Kumar","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.04.029_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011137","article-title":"Insulin resistance and cancer: in search for a causal link","volume":"22","author":"Chiefari","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.04.029_bib106","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41417-024-00729-z","article-title":"Neddylation of insulin receptor substrate acts as a bona fide regulator of insulin signaling and its implications for cancer cell migration","volume":"31","author":"Park","year":"2024","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.apsb.2025.04.029_bib107","first-page":"1232","article-title":"The intracellular mechanism of insulin resistance in pancreatic cancer patients","volume":"85","author":"Liu","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.apsb.2025.04.029_bib108","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4093\/dmj.2021.0077","article-title":"Obesity, diabetes, and increased cancer progression","volume":"45","author":"Kim","year":"2021","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.apsb.2025.04.029_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114244","article-title":"Targeting PI3K\/AKT signaling pathway in obesity","volume":"159","author":"Savova","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2025.04.029_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315330","article-title":"The PI3K\/Akt pathway in meta-inflammation","volume":"23","author":"Acosta-Martinez","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.04.029_bib111","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/nm759","article-title":"PKB\/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization","volume":"8","author":"Shin","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2025.04.029_bib112","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.apsb.2025.04.029_bib113","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2018.03.039","article-title":"IGF2 induces CD133 expression in esophageal cancer cells to promote cancer stemness","volume":"425","author":"Xu","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2025.04.029_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2024.151457","article-title":"Insulin receptor substrate 1 is a novel member of EGFR signaling in pancreatic cells","volume":"103","author":"Tak\u00e1cs","year":"2024","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.apsb.2025.04.029_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-015-1249-2","article-title":"Human pancreatic cancer stem cells are sensitive to dual inhibition of IGF-IR and ErbB receptors","volume":"15","author":"Urtasun","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.apsb.2025.04.029_bib116","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1158\/1078-0432.CCR-18-3001","article-title":"The caspase-3\/PKC\u03b4\/Akt\/VEGF-A signaling pathway mediates tumor repopulation during radiotherapy","volume":"25","author":"Cheng","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2025.04.029_bib117","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1080\/21655979.2022.2036399","article-title":"Bcl-2 interacting protein 3 (BNIP3) promotes tumor growth in breast cancer under hypoxic conditions through an autophagy-dependent pathway","volume":"13","author":"Zhang","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.apsb.2025.04.029_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-00904-3","article-title":"Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy","volume":"13","author":"Hua","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2025.04.029_bib119","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/carcin\/bgu042","article-title":"Cancer cell-associated fatty acid synthase activates endothelial cells and promotes angiogenesis in colorectal cancer","volume":"35","author":"Zaytseva","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.apsb.2025.04.029_bib120","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1158\/0008-5472.CAN-16-3062","article-title":"De novo lipid synthesis facilitates gemcitabine resistance through endoplasmic reticulum stress in pancreatic cancer","volume":"77","author":"Tadros","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2025.04.029_bib121","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/mco2.27","article-title":"Lipid metabolism in cancer progression and therapeutic strategies","volume":"2","author":"Fu","year":"2021","journal-title":"MedComm"},{"key":"10.1016\/j.apsb.2025.04.029_bib122","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1126\/science.abj8894","article-title":"Past history of obesity triggers persistent epigenetic changes in innate immunity and exacerbates neuroinflammation","volume":"379","author":"Hata","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.apsb.2025.04.029_bib123","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.immuni.2017.04.016","article-title":"Metabolic and epigenetic coordination of T cell and macrophage immunity","volume":"46","author":"Phan","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2025.04.029_bib124","first-page":"420","article-title":"Metabolic reprograming in macrophage polarization","volume":"5","author":"Galv\u00e1n-Pe\u00f1a","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2025.04.029_bib125","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1073\/pnas.2000943117","article-title":"Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis","volume":"117","author":"Jing","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2025.04.029_bib126","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.55185","article-title":"The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy","volume":"9","author":"Lim","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.apsb.2025.04.029_bib127","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ijo.2008.229","article-title":"Emerging role of adipose tissue hypoxia in obesity and insulin resistance","volume":"33","author":"Ye","year":"2009","journal-title":"Int J Obes"},{"key":"10.1016\/j.apsb.2025.04.029_bib128","doi-asserted-by":"crossref","first-page":"E877","DOI":"10.1152\/ajpendo.00626.2010","article-title":"Regulation of HIF-1\u03b1 activity in adipose tissue by obesity-associated factors: adipogenesis, insulin, and hypoxia","volume":"300","author":"He","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.apsb.2025.04.029_bib129","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nature06905","article-title":"NF-\u03baB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1\u03b1","volume":"453","author":"Rius","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.029_bib130","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.molimm.2015.08.004","article-title":"Hypoxia-inducible factors regulate T cell metabolism and function","volume":"68","author":"Phan","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.apsb.2025.04.029_bib131","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3389\/fimmu.2019.01462","article-title":"The metabolic signature of macrophage responses","volume":"10","author":"Viola","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2025.04.029_bib132","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ebiom.2018.02.009","article-title":"Interferon gamma induces reversible metabolic reprogramming of M1 macrophages to sustain cell viability and pro-inflammatory activity","volume":"30","author":"Wang","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.apsb.2025.04.029_bib133","doi-asserted-by":"crossref","first-page":"9394","DOI":"10.1038\/s41467-024-53593-8","article-title":"HIF1\u03b1-regulated glycolysis promotes activation-induced cell death and IFN-\u03b3 induction in hypoxic T cells","volume":"15","author":"Shen","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.04.029_bib134","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/imm.13575","article-title":"Metabolic plasticity and regulation of T cell exhaustion","volume":"167","author":"Li","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.apsb.2025.04.029_bib135","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/j.jfma.2022.05.003","article-title":"Increased HIF-1\u03b1 expression in T cells and associated with enhanced Th17 pathway in systemic lupus erythematosus","volume":"121","author":"Liao","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.apsb.2025.04.029_bib136","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1038\/s41467-023-42634-3","article-title":"Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1\u03b1-mediated glycolytic reprogramming","volume":"14","author":"Wu","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.04.029_bib137","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1172\/JCI67230","article-title":"HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations","volume":"123","author":"Semenza","year":"2013","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2025.04.029_bib138","first-page":"1541","article-title":"Modulation of HIF-1\u03b1 expression by the epidermal growth factor\/phosphatidylinositol 3-kinase\/PTEN\/AKT\/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics","volume":"60","author":"Zhong","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2025.04.029_bib139","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41231-023-00135-x","article-title":"Expression of HIF-1\u03b1 and markers of angiogenesis and metabolic adaptation in molecular subtypes of breast cancer","volume":"8","author":"Farooq","year":"2023","journal-title":"Transl Med Commun"},{"key":"10.1016\/j.apsb.2025.04.029_bib140","first-page":"59","article-title":"Complex role of HIF in cancer: the known, the unknown, and the unexpected","volume":"2","author":"Denise Tiburcio","year":"2014","journal-title":"Hypoxia"},{"key":"10.1016\/j.apsb.2025.04.029_bib141","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2025.04.029_bib142","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2025.04.029_bib143","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/ncb3015","article-title":"The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis","volume":"16","author":"McAllister","year":"2014","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.apsb.2025.04.029_bib144","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature25432","article-title":"Chromosomal instability drives metastasis through a cytosolic DNA response","volume":"553","author":"Bakhoum","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.029_bib145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.apsb.2025.04.029_bib146","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2025.04.029_bib147","doi-asserted-by":"crossref","first-page":"10862","DOI":"10.1158\/0008-5472.CAN-05-1231","article-title":"Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell\u2013adipocyte interaction\/crosstalk at the tumor invasive front","volume":"65","author":"Andarawewa","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2025.04.029_bib148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00017.2012","article-title":"Hypoxia and adipose tissue function and dysfunction in obesity","volume":"93","author":"Trayhurn","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.apsb.2025.04.029_bib149","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gene.2017.04.021","article-title":"Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India","volume":"621","author":"Sultana","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.apsb.2025.04.029_bib150","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.semcancer.2019.09.001","article-title":"The weight of obesity in breast cancer progression and metastasis: clinical and molecular perspectives","volume":"60","author":"Barone","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.apsb.2025.04.029_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-014-0426-6","article-title":"Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway","volume":"16","author":"Alshaker","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.apsb.2025.04.029_bib152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-019-0778-6","article-title":"Cancer-associated adipocytes: key players in breast cancer progression","volume":"12","author":"Wu","year":"2019","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2025.04.029_bib153","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1158\/0008-5472.CAN-13-0926","article-title":"Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis","volume":"73","author":"Arendt","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2025.04.029_bib154","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1158\/0008-5472.CAN-11-3567","article-title":"CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells","volume":"72","author":"Tsuyada","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2025.04.029_bib155","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.8336","article-title":"Adipose microenvironment promotes triple negative breast cancer cell invasiveness and dissemination by producing CCL5","volume":"7","author":"D'Esposito","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2025.04.029_bib156","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/hep.28874","article-title":"IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice","volume":"65","author":"Bergmann","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2025.04.029_bib157","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.4049\/jimmunol.175.2.1197","article-title":"Macrophages induce invasiveness of epithelial cancer cells via NF-\u03baB and JNK","volume":"175","author":"Hagemann","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2025.04.029_bib158","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.apsb.2025.04.029_bib159","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/NT.0000000000000167","article-title":"The gut microbiome and its role in obesity","volume":"51","author":"Davis","year":"2016","journal-title":"Nutr Today"},{"key":"10.1016\/j.apsb.2025.04.029_bib160","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.029_bib161","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4065\/83.4.460","article-title":"Gut microbiota and its possible relationship with obesity","volume":"83","author":"DiBaise","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.apsb.2025.04.029_bib162","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nm.4358","article-title":"Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention","volume":"23","author":"Liu","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2025.04.029_bib163","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2337\/dc17-2108","article-title":"Changes in gut microbiota\u2013related metabolites and long-term successful weight loss in response to weight-loss diets: the POUNDS Lost trial","volume":"41","author":"Heianza","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.apsb.2025.04.029_bib164","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity","volume":"110","author":"Everard","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2025.04.029_bib165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041079","article-title":"Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity","volume":"7","author":"Gauffin Cano","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2025.04.029_bib166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2009.06.001","article-title":"The search for infectious causes of human cancers: where and why","volume":"392","author":"Zur","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.apsb.2025.04.029_bib167","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00432-018-2816-0","article-title":"Microbiota in cancer development and treatment","volume":"145","author":"Raza","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.apsb.2025.04.029_bib168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11912-014-0406-0","article-title":"Cancer-promoting effects of microbial dysbiosis","volume":"16","author":"Sheflin","year":"2014","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.apsb.2025.04.029_bib169","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.1224820","article-title":"Intestinal inflammation targets cancer-inducing activity of the microbiota","volume":"338","author":"Arthur","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.apsb.2025.04.029_bib170","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/1078-0432.CCR-13-1343","article-title":"Colonization of the human gut by E. coli and colorectal cancer risk","volume":"20","author":"Bonnet","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2025.04.029_bib171","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41467-020-20422-7","article-title":"Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma","volume":"12","author":"Behary","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.04.029_bib172","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2017.12.019","article-title":"Cancer, obesity and immunometabolism\u2013Connecting the dots","volume":"417","author":"Dyck","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2025.04.029_bib173","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.029_bib174","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2025.04.029_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110986","article-title":"Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-\u03b2 signaling in regulatory T cells","volume":"39","author":"Gu","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2025.04.029_bib176","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1038\/s41467-022-32521-8","article-title":"Lactate increases stemness of CD8+ T cells to augment anti-tumor immunity","volume":"13","author":"Feng","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.04.029_bib177","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.molcel.2019.10.023","article-title":"Cancer-derived succinate promotes macrophage polarization and cancer metastasis via succinate receptor","volume":"77","author":"Wu","year":"2020","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2025.04.029_bib178","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.cmet.2022.06.008","article-title":"Tumor cells dictate anti-tumor immune responses by altering pyruvate utilization and succinate signaling in CD8+ T cells","volume":"34","author":"Elia","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2025.04.029_bib179","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41419-023-05576-8","article-title":"Obesity promotes radioresistance through SERPINE1-mediated aggressiveness and DNA repair of triple-negative breast cancer","volume":"14","author":"Su","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2025.04.029_bib180","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1002\/cncr.29472","article-title":"Impact of obesity on outcomes after definitive dose-escalated intensity-modulated radiotherapy for localized prostate cancer","volume":"121","author":"Wang","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.apsb.2025.04.029_bib181","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/cncr.31976","article-title":"Obesity and cancer treatment efficacy: existing challenges and opportunities","volume":"125","author":"Ross","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.apsb.2025.04.029_bib182","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3816\/CBC.2002.n.023","article-title":"Clinical utility of urokinase-type plasminogen activator and plasminogen activator inhibitor\u20141 determination in primary breast cancer tissue for individualized therapy concepts","volume":"3","author":"Harbeck","year":"2002","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.apsb.2025.04.029_bib183","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1200\/JCO.2015.61.6375","article-title":"Randomized trial comparing telephone versus in-person weight loss counseling on body composition and circulating biomarkers in women treated for breast cancer: the lifestyle, exercise, and nutrition (LEAN) study","volume":"34","author":"Harrigan","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2025.04.029_bib184","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1249\/MSS.0000000000002116","article-title":"Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable","volume":"51","author":"Campbell","year":"2019","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.apsb.2025.04.029_bib185","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12967-022-03851-4","article-title":"Glucose metabolic reprogramming and its therapeutic potential in obesity-associated endometrial cancer","volume":"21","author":"Huang","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.apsb.2025.04.029_bib186","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ijc.20284","article-title":"Biomarkers of dietary fatty acid intake and the risk of breast cancer: a meta-analysis","volume":"111","author":"Saadatian-Elahi","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.apsb.2025.04.029_bib187","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f3706","article-title":"Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies","volume":"346","author":"Zheng","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.apsb.2025.04.029_bib188","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1038\/sj.bjc.6601314","article-title":"Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature","volume":"89","author":"Boyd","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.apsb.2025.04.029_bib189","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.semcancer.2023.05.002","article-title":"Obesity-induced changes in cancer cells and their microenvironment: mechanisms and therapeutic perspectives to manage dysregulated lipid metabolism","volume":"93","author":"Lee-Rueckert","year":"2023","journal-title":"InSemin Cancer Biol"},{"key":"10.1016\/j.apsb.2025.04.029_bib190","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.577420","article-title":"Alterations of lipid metabolism in cancer: implications in prognosis and treatment","volume":"10","author":"Fern\u00e1ndez","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.apsb.2025.04.029_bib191","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.3390\/ijms23052705","article-title":"Metformin and breast cancer: where are we now?.","volume":"23","author":"Cejuela","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.04.029_bib192","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pcd.2020.06.001","article-title":"Metformin and risk of cancer among patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"15","author":"Zhang","year":"2021","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.apsb.2025.04.029_bib193","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00228-022-03444-6","article-title":"Effect of metformin as an adjuvant therapy to letrozole on estradiol and other biomarkers involved in the pathogenesis of breast cancer in overweight and obese postmenopausal women: a pilot study","volume":"79","author":"El-Attar","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.apsb.2025.04.029_bib194","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/cncr.26439","article-title":"Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer","volume":"118","author":"Bayraktar","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.apsb.2025.04.029_bib195","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1517\/14656566.1.4.841","article-title":"Orlistat in the treatment of obesity","volume":"1","author":"Ballinger","year":"2000","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.apsb.2025.04.029_bib196","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.824269","article-title":"The effect of orlistat on sterol metabolism in obese patients","volume":"13","author":"Kwon","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.apsb.2025.04.029_bib197","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/ijc.23835","article-title":"Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model","volume":"123","author":"Carvalho","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.apsb.2025.04.029_bib198","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/13543784.2018.1471132","article-title":"Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy","volume":"27","author":"Schcolnik-Cabrera","year":"2018","journal-title":"Expet Opin Invest Drugs"},{"key":"10.1016\/j.apsb.2025.04.029_bib199","doi-asserted-by":"crossref","DOI":"10.1126\/science.aag2770","article-title":"Chemical transformation of xenobiotics by the human gut microbiota","volume":"356","author":"Koppel","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.apsb.2025.04.029_bib200","article-title":"A review of gut microbiota-derived metabolites in tumor progression and cancer therapy","volume":"10","author":"Yang","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.apsb.2025.04.029_bib201","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1126\/science.aaz7015","article-title":"Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response","volume":"374","author":"Spencer","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.apsb.2025.04.029_bib202","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1126\/science.adn4128","article-title":"The benefits of GLP-1 drugs beyond obesity","volume":"385","author":"Drucker","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.apsb.2025.04.029_bib203","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.901559","article-title":"Effects of GLP-1 receptor agonists on biological behavior of colorectal cancer cells by regulating PI3K\/AKT\/mTOR signaling pathway","volume":"13","author":"Tong","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2025.04.029_bib204","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.2337\/db13-1169","article-title":"Exendin-4, a GLP-1 receptor agonist, attenuates prostate cancer growth","volume":"63","author":"Nomiyama","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.apsb.2025.04.029_bib205","doi-asserted-by":"crossref","DOI":"10.1177\/1559325821995651","article-title":"Anti-proliferative activity of glucagon-like peptide-1 receptor agonist on obesity-associated breast cancer: the impact on modulating adipokines' expression in adipocytes and cancer cells","volume":"19","author":"Alanteet","year":"2021","journal-title":"Dose Response"},{"key":"10.1016\/j.apsb.2025.04.029_bib206","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41587-019-0329-2","article-title":"The therapeutic landscape for cells engineered with chimeric antigen receptors","volume":"38","author":"MacKay","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2025.04.029_bib207","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1016\/S1470-2045(19)30729-6","article-title":"CAR T-cell product performance in haematological malignancies before and after marketing authorisation","volume":"21","author":"Elsallab","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.apsb.2025.04.029_bib208","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41571-021-00476-2","article-title":"Immunogenicity of CAR T cells in cancer therapy","volume":"18","author":"Wagner","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2025.04.029_bib209","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","article-title":"Targeting cardiac fibrosis with engineered T cells","volume":"573","author":"Aghajanian","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.029_bib210","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic CAR T cells reverse senescence-associated pathologies","volume":"583","author":"Amor","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.029_bib211","doi-asserted-by":"crossref","first-page":"C1085","DOI":"10.1152\/ajpcell.00034.2022","article-title":"Thermogenic T cells: a cell therapy for obesity?.","volume":"322","author":"Beier","year":"2022","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525002965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525002965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:22:08Z","timestamp":1762604528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383525002965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":211,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2211383525002965"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2025.04.029","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity\u2013cancer axis crosstalk: Molecular insights and therapeutic approaches","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2025.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}